BRIEF-Pfizer's Abrysvo Gets Positive CHMP Opinion For Adults Aged 18 To 59

Reuters
03 Mar
BRIEF-Pfizer's Abrysvo Gets Positive CHMP Opinion For Adults Aged 18 To 59

March 3 (Reuters) - Pfizer Inc PFE.N:

  • PFIZER’S ABRYSVO GETS POSITIVE CHMP OPINION FOR ADULTS AGED 18 TO 59

  • PFIZER: EUROPEAN COMMISSION TO REVIEW CHMP RECOMMENDATION AND IS EXPECTED TO MAKE FINAL DECISION IN COMING MONTHS

Further company coverage: PFE.N

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10